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Direct Myocardial Depressant Effect of
Methylmethacrylate Monomer
Mechanical and Electrophysiologic Actions in vitro
Ki Jun Kim, M.D.,* Da Guang Chen, M.D.,† Namsik Chung, M.D.,‡ Carl Lynch III, M.D., Ph.D.,§ Wyun Kon Park, M.D.
Background: The present study explored the mechanism of
direct myocardial depression by methylmethacrylate monomer
(MMA).
Methods: Isometric contraction of isolated guinea pig right
ventricular papillary muscle was measured in modified normal
and 26 mM K Tyrode solutions at various stimulation rates.
Normal and slow action potentials were evaluated by conven-
tional microelectrode technique. MMA effects on various as-
pects of sarcoplasmic reticulum function were evaluated by its
effect on rapid-cooling contractures, rested-state contraction in
rat papillary muscle in modified normal Tyrode solution, and in
guinea pig papillary muscle under low Na (25 mM) Tyrode
solution. Whole cell patch clamp techniques were applied to
measure the inward Ca2 currents (ICa).
Results: MMA (0.5, 1.5, and 4.7 mM) caused concentration-
dependent depression of peak force and maximal rate of force
development to approximately 70, 50, and 20% of baseline from
rested state to 3 Hz stimulation rates, respectively. Depression
of peak force and maximal rate of force development by MMA
was dependent on stimulation frequency, with less depression
at higher stimulation rates. In low Na Tyrode solution, 1.5 mM
MMA depressed peak force of rat and guinea pig myocardium
by 20–30%. In 26 mM K Tyrode solution, 0.5 and 1.5 mM MMA
caused selective and marked concentration-dependent depression
of late force development (0.5 mM: approximately 60% of baseline,
1.5 mM: approximately 30% of baseline) with no alteration in early
force development. MMA (1.5 mM) depressed rapid-cooling con-
tracture to 53  10% of baseline, accompanied by approximately
63% prolongation of time to peak contracture. In patch clamp
studies, MMA reduced ICa in a concentration-dependent manner.
Conclusions: The direct myocardial depressant effect of MMA
seems to be caused in part by depression of Ca2 influx through
cardiac membrane, while depolarization-activated sarcoplas-
mic reticulum Ca2 release appears modestly depressed.
METHYLMETHACRYLATE monomer (MMA), an aro-
matic volatile liquid, is one component of acrylic bone
cements and has been employed in orthopedic surgical
procedures to anchor prosthetic devices to bone. After
exposure to MMA, transient systemic hypotension can
occur in anesthetized patients within seconds or min-
utes1,2 and, occasionally, can progress to cardiovascular
collapse, cardiac arrest, and death.3,4 Several mecha-
nisms have been proposed as causes of this hemody-
namic effect, including direct vasodilation,5 direct myo-
cardial depression,6,7 pulmonary embolization of bone
marrow fat,8 air,9 platelet aggregates,10 and complement
activation with release of anaphylatoxins.11
Direct myocardial depressant action of MMA has been
proposed and demonstrated in humans12 and in vivo7
and in vitro6,13 animal studies. Although indirect evi-
dence exists for inhibition of Ca2 entry as a cause of
contractile depression in isolated rat and rabbit atrium,6
in isolated vascular smooth muscle in rabbit,5 and in rat
uterine preparation,14 the exact mechanisms that con-
tribute to direct myocardial depression have not yet
been clearly defined. The present study was undertaken
to elucidate the mechanism of action of MMA on direct




Experiment with Modified Normal Tyrode Solu-
tion. Following a procedure approved by the Yonsei
University College of Medicine Animal Research Com-
mittee, the heart was removed from female guinea pigs
(400–450 g) or Sprague–Dawley rats (400–450 g) after
inhalation anesthesia with halothane 2.5–4 vol%. The
right ventricular papillary muscles were excised,
mounted horizontally in a tissue bath, and superfused
(8 ml/min) at 37°C with modified normal Tyrode solu-
tion (mM: 143 Na, 5 K, 2 Ca2, 127 Cl, 1.2 MgSO4,
25 HCO3
, 11 glucose, 0.10 EDTA). EDTA was used to
chelate trace contaminant heavy metals. Solution was
circulated through the bath from unsealed reservoirs
through which 95% O2 and 5% CO2 was bubbled (flow
rate: 500 ml/min) maintaining pH at 7.4  0.5. The
tendinous end of the papillary muscle was attached to a
Grass FT03 force transducer (GRASS Instruments,
Quincy, MA) while the other end of the muscle was
pinned to the bottom of the tissue bath. Muscle length
was adjusted to the lowest resting force at which maxi-
mum twitch force was obtained. The muscles were stim-
ulated at 0.5 Hz for 60 min for stabilization. The muscles
were field-stimulated by a GRASS S44 stimulator (GRASS
Instruments) at an intensity of approximately 120% of
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the lowest level that elicited a response. After a 15-min
rest, a rested-state (RS) contraction was elicited followed
by stimulation rates of 0.1, 0.5, 1, 2, and 3 Hz sequen-
tially. At each stimulation rate except RS, duration of
stimulation was preset and kept constant during the
experiment. Following baseline measurements, muscles
were exposed to each calculated concentration of MMA
(3, 10, and 30 mM) for 15 min successively before the
recording of responses. A 15 min application of MMA
was sufficient to produce a stable and consistent effect
in pilot experiments. Concentrations were referenced
by an in vitro vascular smooth muscle study5 and deter-
mined by preliminary experiments on contractile force
in modified normal Tyrode solution. Recovery responses
were measured after washout for 20 min. Effects on
contractile function are presented as peak force (PF) and
maximal rate of force development (dF/dt-max).
After each experiment, the muscle cross-sectional area
was estimated from muscle length, weight, and density
(1.04 g/ml), assuming a cylindrical form. Mean cross-
sectional areas were 0.83  0.32 mm2 (n  32), ranged
from 0.24 to 1.46 mm2, and 0.55  0.38 mm2 (n  8),
ranged from 0.14 to 1.22 mm2, in guinea pigs and rats,
respectively. Thirteen muscles were used for action po-
tential (AP) experiments and 21 myocytes were used for
electrophysiologic measurement.
To evaluate MMA effects on Ca2 release by rapid
depolarization from the sarcoplasmic reticulum (SR), rat
papillary muscles were used. Following baseline mea-
surements at RS, muscles were exposed to 10 mM MMA
for 15 min. Recovery responses were measured follow-
ing washout for 20 min.
Rapid Cooling Contracture. When isolated strips of
myocardium are rapidly cooled, a contracture develops
as a result of sudden release of Ca2 from the SR, used as
an index of the SR Ca2 content.15 Rapid cooling con-
tracture (RCC) was triggered by rapidly changing the
perfusion from 37°C to 0°C solution (flow rate: approx-
imately 50 ml/min) and changing the temperature to
lower than 5°C within 2–4 s. When rapid cooling fol-
lowed abrupt cessation of 2 Hz stimulation, a transient
contracture resulted, which peaked after 10–12 s and
gradually declined to near the diastolic resting force at
50–60 s. After baseline RCC measurement, the muscle
was exposed to 10 mM MMA for 15 min (unstimulated),
followed by muscle stimulation at 0.1, 1, and 2 Hz
stimulation rates, yielding a stable contraction. The du-
ration of stimulation at each stimulation rate was preset
and kept during the experiment. As in the control set-
ting, rapid cooling was applied immediately after cessa-
tion of stimulation. The isometric force and bath tem-
perature were continuously recorded during the
experiments, and recovery responses were observed fol-
lowing washout for 20 min.
Experiment with Low Na (25 mM) Tyrode Solu-
tion. Experiments using guinea pig papillary muscles
with low Na (25 mM) Tyrode solution (mM: 25 Na,
5°K, 9 Cl, 2 Ca2, 1.2 MgSO4, 25 HCO3
, 11 glucose,
0.1 EDTA, 234 sucrose) were performed to confirm
actions in rat force studies and to rule out the species-
dependent differences in SR Ca2 release. Because Ca2
extrusion via the Na–Ca exchange is markedly reduced
by low extracellular Na concentration, Ca2 is accumu-
lated in SR during rest and causes enhanced contraction
at RS and low-stimulation rates. The contraction in low
Na Tyrode solution does not require a large inward
Ca2 current (ICa), as evidenced by the fact that its
inhibition by nifedipine in this preparation does not alter
the contractile force.16 After obtaining baseline measure-
ments at RS after 15 min rest, muscles were exposed to
10 mM MMA for 15 min. Recovery responses were mea-
sured following washout for 20 min.
Experiment with 26 mM K Tyrode Solution.
Guinea pig papillary muscles were used to observe the
effect on biphasic contraction and slow AP, which can
be observed in 26 mM K Tyrode solution (mM: 122 Na,
26°K, 121 Cl, 2 Ca2, 1.2 MgSO4, 25 HCO3
, 11
glucose, 0.1 EDTA), which causes partial depolarization
to 40 to 45 mV and inactivates fast sodium channels.
Concurrent application of 0.1 M isoproterenol results in
an increase in open probability of Ca2 channels via the
-adrenergic pathway to permit the measurement of
slow APs. Under these conditions, contractility, inward
Ca2 current,17 and Ca2 uptake into the SR are en-
hanced.18 The pattern of force after rest and up to 0.5–
1 Hz stimulation rate consistently demonstrated a dis-
tinct early and late phase of force development (dFE/dt-
max and dFL/dt-max, respectively).
19 While the early
peak of the biphasic contraction elicited under a variety
of conditions in various species is activated by Ca2 that
was accumulated during prior depolarizations and re-
leased immediately upon rapid depolarization of the
membrane, late-peaking force is due to the Ca2 that
enters the cell during initial phase of AP, is taken up into
the SR, and subsequently released late in depolariza-
tion.16 The late PF is inhibited by inhibitors of Ca2 entry
such as nifedipine16 and Mn.20 In contrast, ryanodine
decreases the initial force development19 by putting the
Ca2 channel in a low conductance state and decreasing
SR Ca2 available for release.21 Increasing concentra-
tions of MMA (3 and 10 mM) were applied sequentially in
contractile force experiments. Recovery responses were
measured following washout for 20 min.
Electrophysiologic Studies
Papillary Muscles. Papillary muscle membrane po-
tential was monitored by conventional 3 M KCl-filled
glass microelectrodes (10–20 M) attached to a VF-1
preamplifier (World Precision Instruments, Sarasota, FL).
Membrane potential and its maximal rate of rise during
1187METHYL METHACRYLATE MONOMER AND MYOCARDIAL DEPRESSION
Anesthesiology, V 98, No 5, May 2003
the AP (dV/dt-max) were monitored on a digital storage
oscilloscope. Because higher stimulation rates (2 and
3 Hz) frequently caused dislodgement of impaled micro-
electrodes, only results from an impalement maintained
throughout the whole sequence at 0.25 Hz stimulation
rate were tabulated. Stimulation intensity was main-
tained at approximately 120% of the lowest intensity
necessary to elicit a response and then adjusted to main-
tain approximately the same latency (stimulus-AP inter-
val, usually 5–10 ms). AP amplitude, dV/dt-max, and AP
duration at 30, 50, and 90% repolarization (APD30,
APD50, and APD90, respectively) were measured at
0.25 Hz stimulation rate in modified normal Tyrode so-
lution and in 26 mM K Tyrode solution with 0.1 M
isoproterenol.
Isolated Myocyte Studies. Whole-cell voltage clamp
measurements were applied to isolated myocytes to ex-
amine the effect of MMA on Ca2 current. Guinea pig
ventricular myocytes were isolated enzymatically as pre-
viously described.22 Guinea pigs (~300 g) were anesthe-
tized with 50 mg/kg sodium pentobarbital according to
the guidelines of the University of Virginia Animal Care
and Use Committee. The heart was quickly excised,
perfused by a Langendorff system with modified normal
Tyrode solution for 10 min, followed by perfusion for 5
min with nominally Ca2-free Tyrode solution that
caused cessation of the contractions. The Ca2-free
buffer was then supplemented with 25 M CaCl2,
0.5 mg/ml albumin, and 0.5 mg/ml type II collagenase
(Worthington Biochemical, Freehold, NJ) and continu-
ously recirculated. After 20 min, ventricles were excised,
minced with scissors into the enzyme solution, and agi-
tated by slow bubbling of the solution with 95% O2 and
5% CO2 for 30 min. The resulting slurry was filtered
through 200-m nylon meshes and centrifuged for 2 min
at 80g. Cells were then washed twice in Krebs–Henseleit
buffer with 200 M CaCl2, resuspended in the buffer
with 1 mM CaCl2, and stored in a 95% air and 5% CO2
incubator set at 37°C.
The external bathing solution contained (in mM):
140 Na, 5 K, 2 Ca2, 1 Mg2, 151 Cl, 10 HEPES,
adjusted to pH 7.4 with 1 N NaOH. For measurement of
inward Ca2 current (ICa), the patch pipette solution
contained (in mM): 120 Cs, 20 tetraethylammonium,
1 Ca2, 140 Cl, 11 ethylene glycol-bis(-aminoethyl
ether)-N,N,N,N-tetra-acetic acid, 10 HEPES, 5 Mg-adeno-
sine triphosphate, adjusted to pH 7.3 with 1 N HCl.
Standard whole-cell voltage clamp methods were em-
ployed,23 using the Axopatch 200 (Axon instruments,
Foster city, CA) patch clamp amplifier. Once whole-cell
recording was achieved, the bathing solution was ex-
changed to (in mM): 125 Cs, 20 tetraethylammonium,
2 Ca2, 1 Mg, 151 Cl, 10 HEPES, adjusted to pH 7.4
with 1 M CsOH. Patch electrodes were prepared from
borosilicate glass model KIMAX-51 (American Scientific,
Charlotte, NC) heat-polished with a micro-forge, giving
resistances of 2 and 3 M when filled with internal
solution. Myocyte experiments were conducted at room
temperature (20–22°C). Data acquisition was performed
using a pCLAMP system version 6.0.3 (Axon Instru-
ments) coupled with an IBM-compatible, 486-based mi-
crocomputer. Voltage-dependent Ca2 current (ICa, L)
was evoked by step depolarizations from 30 mV to
70 mV from a holding potential of 40 mV.
Drugs
Liquid MMA (2-methylpropenoic acid methyl ester,
molecular weight 100.13) was purchased from Sigma
(St. Louis, MO), as were all other chemicals unless oth-
erwise noted. For the papillary muscle experiments, an
appropriate aliquot of liquid MMA was added to the
volume of the perfusate to achieve the final calculated
concentrations of 3, 10, and 30 mM. At 37°C, gas chro-
matographic measurement yielded measured concentra-
tions of 0.5  0.04 (n  4), 1.5  0.1 (n  4), and
4.7  0.1 (n  4) mM MMA in modified normal Tyrode
solution when equilibrated for 15 min with each, suc-
cessive concentration of MMA (3, 10, and 30 mM). The
chromatographic method employed N2 as a carrier gas, a
flame-ionization detector, and a fused silica capillary col-
umn (HP-FFAP, 60 m  0.33 mm inner diameter, film
thickness 0.2 mm) maintained isotherm at 40°C. N-hex-
ene (chromatography grade) was used for liquid–liquid
extraction. Calculation was based on a standard curve
prepared each time.
For isolated myocyte studies, an appropriate aliquot of
liquid MMA was added to the volume of the perfusate to
achieve the final calculated concentrations of 0.5, 0.75,
1.0, and 2.0 mM.
Statistical Analysis
Because there are important differences in baseline
values from one muscle to another, inotropic responses
to each concentration of MMA were expressed as a
percentage of baseline values. In papillary muscle and
isolated myocyte experiments, repeated measures of
analysis of variance followed by Student-Newman-Keuls
test were applied to test for significant differences
among the stimulation rates and among the anesthetic
concentrations. All values are expressed as mean  SD.
A P value less than 0.05 was considered significant.
Results
Effects on Contractility
Experiment with Modified Normal Tyrode Solu-
tion. MMA (0.5, 1.5, and 4.7 mM measured) caused
concentration-dependent depression of PF and dF/dt-
max of approximately 70, 50, and 20% of baseline from
RS to 3 Hz stimulation rates, respectively. At all concen-
trations, the effect of MMA on PF and dF/dt-max seemed
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to be significantly less at 3 Hz when compared to the
other stimulation rates from RS to 2 Hz (figs. 1A and B).
The contractile force was recovered to approximately
50% of baseline following washout for 20 min (data not
shown). To verify the stimulation frequency-dependent
effect of MMA, we examined six muscles where 10 mM
MMA (calculated concentration) was only applied, which
showed significantly less depression at 2 and 3 Hz stimula-
tion rates (figs. 1C and D). In recovery following a 20-min
washout, more recovery was observed at 2 and 3 Hz stim-
ulation rates. To verify the volatile characteristic of MMA,
we examined one muscle where spontaneous recovery of
contractile force to approximately 80% of baseline under
0.5 Hz stimulation rate following 45 min application of
10 mM MMA (calculated concentration) was observed
(baseline: 0.29 mN/mm2, 10 mM: 0.11 mN/mm2, recov-
ery: 0.24 mN/mm2). The baseline values of PF and dF/
dt-max in modified normal Tyrode solution from RS to
3 Hz stimulation rates are shown in table 1.
Rat papillary muscles exhibit negative force-frequency
relationship, which may be related to hypoxia. Because of
potential for hypoxic alteration, especially at higher stimu-
lation rates, the effect of 1.5 mM MMA were only examined
at RS. Depression of PF to 70  17% of baseline at RS
was shown (6.44  5.46 vs. 4.61  4.47 mN/mm2, n  8,
P  0.05). Recovery was complete following a 20-min
washout (6.44  5.46 vs. 5.53  4.63 mN/mm2, NS).
Rapid Cooling Contracture. MMA (1.5 mM) de-
pressed RCC following a 2-Hz stimulation rate to 53 
10% of baseline (3.45  2.69 vs. 1.92  1.76 mN/mm2,
n  7, P  0.05) with prolongation of time-to-peak
contracture (163  40% of baseline, 13.46  2.72 vs.
21.69  5.94 s, P  0.05). Almost complete recovery to
baseline level (86  13% of baseline, 3.45  2.69 vs.
Fig. 1. Effects of methylmethacrylate
monomer (MMA) on myocardial contrac-
tile force in modified normal Tyrode so-
lution. Effects of 0.5 mM, 1.5 mM, and
4.7 mM MMA on peak force (PF) (A) and
maximum rate of force development (dF/
dt-max) (B) at various stimulation rates
in guinea pig papillary muscles (n  6).
Effects of 1.5 mM MMA on PF (C) and
dF/dt-max (D) at each stimulation rate
(n  6). *Differences from baseline (P <
0.05). Differences from stimulation rates
of †2 and ‡1 Hz (P < 0.05).
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3.15 3.00 mN/mm2, NS) was shown in RCC amplitude
following a 20-min washout with returning of time-to-
peak contracture to baseline level (13.46  2.72 vs.
15.26  2.35 s, NS) (fig. 2).
Experiment with Low Na(25 mM) Tyrode Solu-
tion. MMA (1.5 mM) depressed RS contraction to 83 
17% of baseline (2.05  1.51 vs. 1.70  1.20 mN/mm2,
n 6, P 0.05). Complete recovery was shown following
a 20-min washout.
Experiment with 26 mM K Tyrode Solution. MMA
(0.5 and 1.5 mM) caused selective and marked concen-
tration-dependent depression of late force development
(0.5 mM: ~60% of baseline, 1.5 mM: ~30% of baseline)
with no alteration of early force development (figs. 3A–C
and 4A). Complete recovery was shown following a
20-min washout (data not shown). The baseline values of
PF, dFE/dt-max, and dFL/dt-max are shown in table 2.
Electrophysiologic Effect
Papillary Muscles. In normal APs, MMA (1.5 and
4.7 mM) altered neither the amplitude nor dV/dt-max at
0.25 Hz stimulation rate, while APD50 and APD90 were
significantly reduced at 4.7 mM MMA (APD50: 88  10%
of baseline, APD90: 90  8% of baseline) (table 3). No
change in the resting membrane potential, which ranged
from 85 mV to 89 mV, was observed at either con-
centration of MMA. In slow APs, 1.5 and 4.7 mM MMA
did not change either AP amplitude or dV/dt-max at
0.25 Hz stimulation rate as similar as in modified normal
Tyrode solution. AP durations were significantly reduced
by 4.7 mM MMA (APD50: 84  2% of baseline, APD90:
87  1% of baseline, P  0.05) while modest reduction
of AP duration by 1.5 mM MMA was shown (table 3, fig.
4B). No changes in resting membrane potential, which
ranged from 52 mV to 54 mV, were observed at
either concentration of MMA.
Isolated Myocyte Studies. Application of 1 mM MMA
resulted in reduction of peak current of ICa, L to 51  9%
of baseline (538  296 pA vs. 274  161 pA, n  5, P 
0.05) (fig. 5A). As shown in figure 5B, 0.5, 0.75, 1, and
2 mM MMA decreased ICa, L 91  15%, 82  13%, 51 
9%, and 36  13% of baseline, respectively, in a concen-
tration-dependent fashion. The resulting curve was fitted
by the following formula: IMMA/Imax  Kd
n/([MMA]n 
Kd
n). The IMMA and Imax are ICa at baseline and at each
MMA concentration, and Kd is an MMA concentration,
which decreases Imax to the 50% of baseline level. N is
the slope factor, Kd  1.33 mM, and the n  1.93.
Discussion
MMA is an aromatic volatile liquid (boiling point, 100–
101°C) with a density similar to water (0.94 g/ml). The
present study shows that MMA depresses the contractile
force in a concentration-dependent manner with some-
what less depression at higher stimulation rates com-
pared to low stimulation rates. The myocardial depres-
sant action of MMA has been reported in isolated
ventricular tissues,6,13 in intact animals,7 and in clinical
settings.12 Baran et al.6 in their study with isolated rat
and rabbit atria demonstrated approximately 43 and 28%
depression of contractile force, respectively, by 10 mM
MMA. In a rat heart-lung preparation, Kashimoto et al.24
reported that 1000 g/ml (10 mM) MMA caused depres-
sion of cardiac output approximately 50–40% of base-
line. Considering the similar depression of contractile
force in our result, the used, calculated concentration of
the previous studies may be close to the measured con-
centration by gas chromatography since the low solubil-
ity and loss to the atmosphere resulted in lower mea-
sured concentrations than calculated from the amount of
drug.
In a muscle, we observed spontaneous recovery (ap-
Table 1. Baseline Values of Main Mechanical Parameters in
Modified Normal Tyrode Solution
Rested
State 0.1 Hz 0.5 Hz 1 Hz 2 Hz 3 Hz
Peak Force 0.34 0.68 0.68 0.74 2.16 3.86
mN/mm2 0.13 0.29 0.29 0.32 0.91 1.39
dF/dt-max 3.27 6.40 6.13 7.98 30.24 57.23
mN  s1  mm2 1.18 2.81 2.46 3.41 12.49 20.50
Results are mean  SD (n  8).
dF/dt-max  maximum rate of force development.
Fig. 2. Effects of methylmethacrylate monomer (MMA) on the
rapid cooling contractures in guinea pig papillary muscles (n 
7). Steady-state contractile force evoked by 2-Hz stimulation
followed by immediate cooling from 37°C to less than 5°C
achieved within 1.5 s, as shown by the temperature measure-
ment in bottom record. Note the prolongation of the time to
peak contracture with 1.5 mM MMA.
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proximately 80% of a baseline value) at 45 min following
10 mM MMA administration, indicating the volatile char-
acter of MMA. In the present study, the measured con-
centrations of the superfusate by gas chromatography
definitely support the evidence of volatility. Blood clear-
ance of MMA has been reported to be rapid and pulmo-
nary excretion is considered the main mechanism of
elimination. Gentil et al.25 in their measurement of meth-
ylmethacrylate plasma concentrations during total hip
arthroplasty reported that the half-life of MMA was 3.0
0.7 min and 55  8% of MMA was cleared during the
transpulmonary passage.
An interesting observation is that MMA caused less
depression at higher stimulation rates, as shown in fig-
ures 1C and D, which has been interpreted as less dis-
turbance of Ca2 release from the SR than sarcolemmal
Ca2 influx. The SR of the isolated rat ventricle does not
become depleted of Ca2 during rest so that RS contrac-
tion in rat papillary muscle reflects force development
mediated by Ca2 released from the SR.26 Unlike rat
myocardium, Ca2 is depleted progressively during rest
in guinea pig myocardium. However, Ca2 is accumu-
lated in guinea pig SR during rest when extracellular Na
concentration is reduced,16 an effect that has been used
to assess the effect on SR Ca2 release by depolarization
in guinea pig myocardium. The minimal effect of MMA
on RS force development in the present rat experiment
is consistent with a modest effect on SR Ca2 release. To
rule out the species-different effect on Ca2 release from
the SR, the experiment with guinea pig papillary muscle
under low Na Tyrode solution was performed, which
showed a similar depression of RS contraction as in the
Fig. 3. Effects of methylmethacrylate monomer (MMA) on myocardial force development in 26 mM K Tyrode solutions with 0.1 M
isoproterenol (n  6). Average peak force (A), maximum rate of early force development (dFE/dt-max) (B), and late force
development (dFL/dt-max) (C) as a function of stimulation rate. Differences from *baseline (P < 0.05).
Fig. 4. Effects of methylmethacrylate monomer (MMA) on con-
tractile force at 0.1-Hz stimulation rate (A) and slow action
potential at 0.25 Hz in guinea pig papillary muscle (B) in 26 mM
K Tyrode solution with 0.1 M isoproterenol. In A, C, 0.5 mM,
1.5 mM, and R represent control, 0.5, 1.5 mM MMA, and recovery,
respectively. In B, dotted line indicates recovery following a
20-min washout.
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rat experiment, also indicating a modest effect of MMA
on SR Ca2 release.
Our findings in partially depolarized -adrenergically
stimulated myocardium showed marked concentration-
dependent depression of late force development
(0.5 mM: approximately 60% of baseline, 1.5 mM: approx-
imately 30% of baseline) with no alteration of early force
development. As depression of the late contraction is
mediated in part by depression of the transsarcolemmal
Ca2 influx, marked concentration-dependent depres-
sion of late force development by MMA may be caused
by depression of the transsarcolemmal Ca2 influx or by
the reduction of late SR release of Ca2, which repre-
sents transient accumulation into the SR of the entering
Ca2.16,19 During prolonged rest, isolated guinea pig
ventricular muscle becomes depleted of its intracellular
store of Ca2 so that RS contraction and those at low
stimulation rates are dependent on the transsarcolemmal
influx of Ca2 for activation.16 Depression of RS contrac-
tion in our results is consistent with reduction of Ca2
entry or reduction of late SR release of Ca2. Considering
the modest effect on SR Ca2 release, therefore, depres-
sion of the late force development in 26 mM K Tyrode
solution and RS contraction in modified normal Tyrode
solution is likely to be mediated by depression of the
inward Ca2 current.
The RCC provides an index of the availability of acti-
vator Ca2 available for release from the SR15 and the
Ca2 release pathway from the SR activated by rapid
cooling does not appear to be the same Ca2 release
channel by depolarization. Although the pool for Ca2
that generates RCCs and electrically evoked contractions
appears to be the same,21 Feher and Rebeyka27 sug-
gested that electrically evoked contractions and rapid-
cooling induced RCCs might rely on ryanodine-sensitive
and -insensitive pathways, respectively, for Ca2 release
from the SR. In the present study, 1.5 mM MMA de-
pressed the RCC to 53  10% of baseline and prolonged
time to peak contracture to 163  40% of baseline. The
most likely explanation for the depression of the RCC is
the inhibition of rapid cooling-induced Ca2 release
pathway rather than an alteration of SR Ca2 uptake.
In our microelectrode experiments in papillary mus-
cles, we could not observe any alteration of slow AP
dV/dt-max. As dV/dt-max of AP actually measures net
current, simultaneous decrease of inward and outward
currents may have counteracting effect. In our result, the
failure to detect the decrease of the slow AP dV/dt-max
with 1.5 and 4.7 mM MMA do not eliminate possible
depression of Ca2 currents if coincident depression of
K conductance was occurring. Therefore, although K
currents primarily determine AP duration, changes in
Ca2 conductance may also alter the duration of the
ventricular AP. The whole cell voltage-clamp studies
were carried out to directly demonstrate the effect on
Ca2 entry, which revealed a concentration-dependent
Table 2. Baseline Values of Main Mechanical Parameters in 26 mm K Tyrode Solution with 0.1 M Isoproterenol
Rested State 0.1 Hz 0.5 Hz 1 Hz 2 Hz 3 Hz
Peak Force 1.84 1.92 2.00 1.78 1.76 1.83
mN/s/mm2 1.93 2.07 2.07 1.90 1.67 1.60
dFE/dt-max 5.46 5.47 8.55 14.87 28.78 33.97
mN  s1  mm2 3.82 3.81 6.42 11.81 23.74 28.24
dFL/dt-max 16.44 16.78 18.48 13.78
mN  s1  mm2 17.40 17.83 19.39 16.34
Results are mean  SD (n  6).
dFE/dt-max  maximum rate of early force development; dFL/dt-max  maximum rate of late force development.











Normal AP (n  8)
Baseline 130  12 126  43 178  31 217  33 131  34
1.5 mM MMA 129  9 129  49 168  29 206  28 118  31
4.7 mM MMA 133  13 116  40 152  15* 190  17* 118  24*
Recovery 135  13 134  53 188  30* 224  31 141  28
Slow AP (n  5)
Baseline 96  12 13  5 196  25 230  27 166  13
1.5 mM MMA 93  10 13  6 180  17* 218  24 158  20
4.7 mM MMA 89  5 10  3 156  13*† 191  12*† 136  11*
Recovery 94  7 14  6 181  36 208  38* 138  30*
Values are mean  SD.
* Differences from baseline (P  0.05). † Differences from 1.5 mm MMA (P  0.05).
AP  action potential; APD50, APD90, and APD30  duration of AP at 50, 90, and 30% repolarization, respectively; dV/dt-max  the maximum rate of
depolarization of the AP; MMA  methymethacrylate monomer.
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reduction of peak ICa, L. L-type Ca
2 channels are re-
ported to be available to open with depolarization from
a holding potential of 50 mV.28 Shortening of plateau
phase in normal and slow APs in our microelectrode
experiments may reflect the reduction of intracellular
Ca2 entry via Ca2 channel. Baran et al.6 in their study
with isolated rat and rabbit atria observed that the neg-
ative inotropic effect of MMA was reversed by elevating
bath Ca2 concentrations. Waters et al.7 in their in vivo
dog study also found that a Ca2 infusion reversed MMA-
induced depression of cardiac output and stroke vol-
ume. These indirect evidences for decreased intracellu-
lar Ca2 entry also have been suggested by studies of
isolated rabbit venous and aortic rings preconstricted
with either potassium or noradrenaline,5 and potassium
induced contraction of the isolated rat uterine
preparation.14
The depression of ICa by MMA in the present voltage
clamp studies shows a concentration dependence simi-
lar to the depression of contractile forces of guinea pig
papillary muscle in modified normal Tyrode solution.
The IC50, 1.33 mM, in the dose-response curve of ICa may
explain the similar depression of contractile force, ap-
proximately 50% of baseline, by 1.5 mM MMA (by gas
chromatography) in modified normal Tyrode solution.
Since the patch clamp studies typically employed a
shorter exposure interval to the perfusate, the perfusate
was not bubbled, and the bath temperature was main-
tained at room temperature (20–22°C), there would
have been less MMA lost by volatilization and the con-
centration in solution may have been more accurate.
MMA is a volatile compound with short half-life, and to
assess blood concentrations accurately is known to be
difficult. Frequently, MMA concentrations were unde-
tectable.29,30 Wide ranges in MMA blood concentrations
(0–590 M) have been reported in patients undergoing
hip replacement. Concentrations of 0–26 M were
present in pulmonary artery samples taken 3 min after
insertion of cement in 13 patients with total hip replace-
ment10; 2.4–151 M were present in central venous
samples obtained 5 min after insertion of the cement
into the acetabulum and femur in 8 patients31; 0.5–
318.9 M were present in peripheral venous samples
taken 30 s after implantation of the acrylic cement into
the femur in 20 patients32; 0.2–590 M were present in
pulmonary artery, radial artery, and superior vena cava
samples in 15 total hip replacement patients33; and
1–123 M were present in pulmonary artery and radial
artery samples obtained 2 min after insertion of cement
into the acetabulum and femur in 11 patients.25 In con-
trast to these relatively low blood concentrations, Pahuja
et al.30 in their patients undergoing total hip replace-
ment reported an extremely high concentration (20 mM)
of MMA in one of five patients, while the other four
patients’ concentrations ranged between 16 and 110 M.
Based on these common clinical blood concentrations,
the level of applied concentrations, over 3 mM (0.5 mM
by gas chromatography), in this study is higher. Thus,
the direct contribution of MMA itself to cardiac depres-
sion may be less than the other factors, which cause
hypotension during MMA implantation.
In summary, MMA depresses myocardial contractility
directly in a concentration-dependent manner, which
may be at least caused in part by depression of Ca2
influx through cardiac membrane. The rapid initial re-
lease of Ca2 from the SR by depolarization seems to be
modestly inhibited, and a certain release pathway, spe-
cifically induced by rapid cooling, appears to be de-
pressed. Considering the common clinical concentra-
tions, the direct myocardial depressant effect of MMA
may contribute less than the other factors that cause
hypotension after acrylic bone cement implantation dur-
ing orthopedic surgical procedures.
Fig. 5. (A) Effect of 1 mM methylmethacrylate (MMA) on voltage-
sensitive Ca2 current (ICa) evoked from isolated guinea pig
ventricular myocytes at room temperature. L-type ICa (ICa, L)
triggered by a voltage step to 0 mV from a holding potential of
40 mV was obtained. (B) Concentration-dependent depressant
effect of MMA on ICa. Current amplitude of the ICa measured in
the presence of MMA is normalized to the respective baseline
amplitude in the absence of MMA, and thus normalized current
amplitudes of the ICa are plotted as a function of MMA concen-
tration (n  5 at each concentration except 0.1 mM [n  1]). The
apparent dissociation constant and slope factor were 1.33 mM
and 1.93, respectively.
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